The global Cyclophosphamide market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Cyclophosphamide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cyclophosphamide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cyclophosphamide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cyclophosphamide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Baxter
Roxane
GLS Pharma Ltd
Sanofi
CSC PHARMACEUTICALS INTERNATIONAL
LGM Pharma
Pfizer
Merck
Allergan
The Medicines Company
Theravance Biopharma
Basilea Pharmaceutica

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cyclophosphamide Powder
Cyclophosphamide Injection

Segment by Application
Cancer
Autoimmune Diseases
AL Amyloidosis
Other